ISAAA Presents 2019 Biotech Adoption Findings to Stakeholders in Europe and South AmericaJanuary 6, 2021
ISAAA, together with its partners in The Netherlands and Argentina, conducted two separate webinars to share the latest ISAAA report on the Global Status of Commercialized Biotech/GM Crops in 2019 to stakeholders in Europe and South America.
On December 16, 2020, ISAAA, Wageningen University and Research, Public Religion Research Institute, Asociación Agraria de Jóvenes Agricultores, and Farmers Scientists Network jointly organized a webinar for stakeholders in Europe. Prof. Justus Wesseler of the Wageningen University and Research moderated a panel consisting of ISAAA Chair Dr. Paul S. Teng, ISAAA Global Coordinator Dr. Mahaletchumy Arujanan, ISAAA AfriCenter Program Officer Ms. Bibiana Iraki, Mr. Max Kardung of Wageningen University and Research, and Mr. Daniel Magondu of the Society for Biotech Farmers of Kenya.
Kardung, in particular, expressed his appreciation for new plant breeding techniques. He also stressed the importance of shifting from a fossil-based economy to a bio-based economy, especially to combat climate change. To achieve this shift, he said that new breeding technologies need to be supported and Europe is currently falling behind in this field. "Biotechnological innovations are very crucial devices to development in the future. We already know that we cannot stop climate change completely, so we need to start thinking about how to increase our capacity to adapt to these changes that will come. Biotech crops can deliver a lot of tools to manage
A similar webinar was organized for the South American public by ISAAA, the University of Quilmes, the Argentine Chamber of Biotechnology, the Gabriel Moreno University of Bolivia, and the Zamorano University of Honduras on December 18, 2020. Dr. Martin Lema of the University of Quilmes moderated the panel among ISAAA and Dr. Frederico Trucco, Carlos Rivadeneira, and Rogelio Trabanino, representatives of the said partner institutions. The webinar was mostly delivered in Spanish to make sure that the message about the benefits of biotechnology gets clear through the Latin American community. Aside from the ISAAA report delivered by Dr. Paul Teng, the Biotech Crop Adoption and Challenges experienced by both Bolivia and Honduras were also discussed.
ISAAA will continue to hold webinars with its global partners. For more information, send an e-mail to firstname.lastname@example.org.
You might also like:
- Brief 55: Global Status of Commercialized Biotech/GM Crops: 2019
- ISAAA Brief 55-2019: Executive Summary
- ISAAA Shares 2019 Global Biotech Crop Adoption to Stakeholders in the Philippines and Arab Region
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- ISAAA Presents 2019 Biotech Adoption Findings to Stakeholders in Europe and South America
- UBIC Builds NARO Anti-tick Vaccine Team's Capacity for Biosafety Compliance
- CIMMYT Announces Fall Armyworm Tolerant Maize Hybrids for Africa
- Researchers Find Flag Leaves Top Off Rice Photosynthetic Performance
- USDA APHIS Deregulates GE Corn with Enhanced Yield and Herbicide Tolerance Traits
- Price, Nutrition Among Top Factors that Affect Canadian Consumers' Choice to Buy GM Foods
- Scientists Boost Vegetable Oil Production in Plant Leaves
- CSIRO "Gene Sandwich" to Boost Wheat Resistance to Rust
- Bt Cotton Key in Eradicating Destructive Pest from the US and Mexico
- Target-AID and CRISPR-Cas9 Improve Lycopene Content in Tomatoes
- What are TALENs?
- Fast-spreading SARS-CoV-2 Variant in the U.K. Raises More Questions
Read the latest:
- Biotech Updates (September 20, 2023)
- Gene Editing Supplement (September 13, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: